Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
April 3, 2024 08:00 am ETEstimated Read Time: 2 Minutes
Cannabis is more legal now than ever before. Yet, it remains under-researched and stigmatized. The “Cannabis Education and Research Collection” seeks to close the gap between cutting-edge research and public knowledge of the plants’ vast potential by highlighting the perspectives and expertise of the next generation of cannabis professionals who will push the industry forward in the coming decades.
You’re invited to submit a paper for possible publication by Veriheal in our “Cannabis Education and Research Collection.” Veriheal is a healthcare technology company that is the largest facilitator of medical marijuana cards in the nation. Our accompanying blog aims to provide comprehensive education, resources, and knowledge regarding a wide variety of topics related to cannabis and alternative wellness.
For this collection, we welcome research on a range of themes, including but not restricted to:
Discoveries around cannabinoid pharmacology and the medicinal benefits of the cannabis plant
The impact of cannabis legalization from a social science perspective
BIPOC experiences in cannabis education and research
Innovations in cannabis growth and cultivation
Cannabis use by special populations, such as adolescents, pregnant people, individuals with mental health disorders, and older adults, among others
The chemical composition of cannabis strains, profiling cannabinoids, terpenes, and other phytochemicals, and exploring their potential synergistic effects on therapeutic outcomes
Implications for the future of public health, including patterns of use, prevalence of cannabis-related disorders, access to healthcare services, and public perceptions of cannabis use.
If you’re a current student who is a member of a cannabis-related major or doing research about cannabis within your field, we want to hear from you. Papers should be approximately 1000-1500 words in length and formatted according to the Associated Press Stylebook.
We seek to help people live better lives by changing the stigma on cannabis. Our aim is to change the image of alternative medicine by creating more ease for all users, more growth in science, more access for all patients, and more transparency in the industry.
Oklahoma’s medical-only dispensary market gives licensed patients access to a wide range of cannabis products, but every purchase must follow OMMA rules. This guide explains how to find licensed dispensaries, what identification to bring, purchase and possession limits, product testing, pricing, and what to expect during a visit.
Oklahoma’s advertised $25 medical marijuana card renewal covers the physician evaluation, but patients must also pay a separate OMMA license fee. This guide explains the full renewal cost, reduced-fee eligibility, required documents, online renewal steps, processing times, and the new physician recommendation requirement.
An Oklahoma medical marijuana card provides legal protection under state law, but it can still affect employment, commercial driving, firearms, privacy, and federally regulated situations. This guide explains the main consequences to consider before applying, including workplace drug testing, CDL rules, insurance, housing, and registry privacy.
Getting a medical marijuana card in Oklahoma can be completed online, with no specific qualifying condition required for adult applicants. This guide covers eligibility, telehealth evaluations, required documents, OMMA application steps, fees, processing times, and what patients can do once approved.
A same-day telehealth appointment in Oklahoma can get you a physician recommendation quickly, but OMMA still needs to process your medical marijuana license application. This guide explains the timeline, required documents, costs, and when you can legally visit a dispensary while waiting for the physical card.
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.